FORXIGA is a selective and reversible inhibitor of sodium-glucose cotransporter 2 (SGLT2) that works independently of insulin to help remove excess glucose from the body, a unique mode of action not seen in any other currently available treatments.
Stem cells in the adult pancreas have been identified that can be turned into insulin producing cells, a finding that means people with type 1 diabetes might one day be able to regenerate their own insulin-producing cells.
Scientists have developed a once-a-day nasal gel formulation for the delivery of insulin that could put an end to injections for Type 1 diabetes sufferers.
We all know that sugar is the enemy of sight. But what we generally worry about are various sorts of retinopathies: bleeding and/or jacked-up growth of capillaries in the back of the eyeballs that can cause partial or total blindness. Cataracts, however, are a horse of a different color altogether.
Novo Nordisk’s new ultra long-acting insulin degludec is associated with a higher heart risk than other diabetes treatments, although the size of the risk is uncertain, U.S. regulators said on Tuesday.
BD’s latest advancement in injection comfort, PentaPoint is a patented 5-bevel needle tip design that creates a flatter, thinner surface to help penetrate the skin with significantly greater ease.
Yesterday, the FDA’s Endocrinologic & Metabolic Drug Advisory Committee voted to recommend approval for degludec, a new long acting insulin for the treatment of type 1 and type 2 diabetes.
The researchers found that an ingredient in green tea helps reduce blood sugar spikes in mice, leading to the possibility of a new diet for people.
A research team from the University of Georgia in the US enlisted 51 students to perform two tasks of self control.
Debiotech of Lausanne, Switzerland is bringing to the worldwide market its JewelPUMP insulin delivery device. The JewelPUMP carries 500 Units of insulin, providing a week’s worth use without having to change the pump.
A diabetes blogger experience on using the Medtronic MySentry product for a few months.
Lilly says its once-weekly injectible drug, dulaglutide, has outperformed three other widely taken diabetes drugs in three just-concluded Phase III studies.
A hypoglycemic event and a high rate of glucose excursions were associated with an increased rate of ventricular tachycardia, in a study of 30 patients.
C8 MediSensors, a San Jose, California company, maybe making a bit of history by receiving the European CE Mark for their Optical Glucose Monitor System.
To avoid the little finger for fingerstick tests. Why is that?
It’s a precursor to diabetes, but it also can be reversed. Insulin resistance is a fuzzy, often misunderstood concept. Here, we answer five common questions.
Nadia Al-Samarrie writes an article on an interesting hypoglycemic symptom.
Consumer Reports published a rating system and ranking of the top 21 glucose meters available in the United States in their November issue.
Are you a person with diabetes who has a friend also living with diabetes? And do the two of you want to share blood sugars, and other highs and lows of living with diabetes?
A walk through airport security could prove to be more than a minor hassle for people with diabetes who have an insulin pump or sensor.